CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
Ha-Young Park, In-Jae Oh, Bo Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Cheol Kyu Park, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim, Yoo-Duk Choi
Tuberc Respir Dis. 2019;82(3):227-233.   Published online February 28, 2019
DOI: https://doi.org/10.4046/trd.2018.0070

Excel Download

48P Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression
Journal of Thoracic Oncology. 2018;13(4):S25   Crossref logo
Link1 Link2

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
Tuberculosis and Respiratory Diseases. 2019;82(3):227   Crossref logo
Link1 Link2 Link3

Altered expression of programmed death-ligand 1 after neo-adjuvant chemotherapy in patients with lung squamous cell carcinoma
Lung Cancer. 2016;99:166-171   Crossref logo
Link1 Link2

ASO Author Reflections: Clinical Implications of Programmed Death-Ligand 2 (PD-L2) Expression as an Independent Prognostic Marker in Lung Adenocarcinoma: Different Characteristics of PD-L2-Positive Patients from Those with Programmed Death-Ligand 1
Annals of Surgical Oncology. 2019;26(S3):668-669   Crossref logo
Link1 Link2 Link3

P3.01-77 Clinical Characteristics of Korean Lung Cancer Patients with Programmed Death-Ligand 1 Expression
Journal of Thoracic Oncology. 2018;13(10):S896-S897   Crossref logo
Link1 Link2

Programmed Cell Death Ligand 1 Expression in Non–Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study
Clinical Lung Cancer. 2018;19(5):e667-e673   Crossref logo
Link1 Link2

Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients
Cancer Cytopathology. 2018;126(4):264-274   Crossref logo
Link1 Link2

A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non–Small-Cell Lung Cancer Patients
Clinical Lung Cancer. 2017;18(5):572-582.e1   Crossref logo
Link1 Link2

70 Heterogeneity of programmed death-ligand 1 expression in multifocal lung cancer
Lung Cancer. 2016;91:S25-S26   Crossref logo
Link1 Link2

PROGRAMMED CELL DEATH-LIGAND 1 EXPRESSION AND IMMUNOSCORE IN STAGE II AND III NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
Respirology. 2017;22:113-113   Crossref logo
Link1 Link2